Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ARROWHEAD PHARMACEUTICALS, INC. | COO and General Counsel | Common Stock | 464K | $17.4M | $37.37 | Jan 5, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Jan 3, 2024 | 9 | -$1.14M | 4 | Jan 5, 2024 | COO and General Counsel |
ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Jan 5, 2023 | 2 | -$561K | 4 | Jan 6, 2023 | COO and General Counsel |
ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Jan 3, 2023 | 9 | -$671K | 4 | Jan 5, 2023 | COO and General Counsel |
ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Dec 21, 2022 | 2 | $197K | 4 | Dec 22, 2022 | General Counsel |
ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Jan 5, 2022 | 6 | -$2.01M | 4 | Jan 7, 2022 | General Counsel |
ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Dec 31, 2021 | 3 | $172K | 4 | Jan 4, 2022 | General Counsel |